First Manhattan
PAVM icon

First Manhattan’s PAVmed PAVM Stock Holding History

First Manhattan’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Buy
23,805
+2
+0% +$19 ﹤0.01% 694
2025
Q4 		$158K Hold
23,803
– – ﹤0.01% 709
2025
Q3 		$308K Hold
23,803
– – ﹤0.01% 623
2025
Q2 		$429K Hold
23,803
– – ﹤0.01% 563
2025
Q1 		$515K Buy
23,803
+470
+2% +$9.74K ﹤0.01% 491
2024
Q4 		$439K Buy
23,333
+3,333
+17% +$98.5K ﹤0.01% 526
2024
Q3 		$738K Buy
20,000
+3,333
+20% +$102K ﹤0.01% 412
2024
Q2 		$408K Buy
16,667
+2,500
+18% +$125K ﹤0.01% 512
2024
Q1 		$910K Buy
14,167
+7,500
+112% +$567K ﹤0.01% 386
2023
Q4 		$824K Buy
6,667
+4,445
+200% +$524K ﹤0.01% 403
2023
Q3 		$295K Buy
+2,222
New +$345K ﹤0.01% 583

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

First Manhattan's PAVM Position: Q1 2026 in Review

First Manhattan increased its PAVmed (PAVM) stake by 0.01% in Q1 2026, buying an estimated $19 and bringing the position to 23,805 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #694.

First Manhattan first reported a position in PAVM in Q3 2023 and has held it in 11 quarters since. The position peaked at $910K in Q1 2024. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • First Manhattan held 23,805 shares of PAVmed worth $242K as of Q1 2026.
  • First Manhattan bought 2 PAVmed shares in Q1 2026, an estimated $19.
  • PAVmed made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #694 holding.
  • First Manhattan first reported a position in PAVmed in Q3 2023 and has held it in 11 quarters since.
  • First Manhattan's PAVmed position peaked at $910K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.